NeOnc Announces Abu Dhabi DOH Grants IND Status For NEO212, Orally Administered Perillyl Alcohol-Temozolomide Carbamate Conjugate Being Developed For Patients With Aggressive Brain Tumors

Loading news article.

NeOnc Announces Abu Dhabi DOH Grants IND Status For NEO212, Orally Administered Perillyl Alcohol-Temozolomide Carbamate Conjugate Being Developed For Patients With Aggressive Brain Tumors | WAPE

NeOnc Announces Abu Dhabi DOH Grants IND Status For NEO212, Orally Administered Perillyl Alcohol-Temozolomide Carbamate Conjugate Being Developed For Patients With Aggressive Brain Tumors

Article summary

Related companies

Comments —